Areteia Therapeutics introduces dexpramipexole, a novel oral drug in Phase 3 trials for asthma and COPD, aiming for approval ...

Harvey Jones hails the brilliant long-term performance of the AstraZeneca share price, but wonders whether the FTSE 100's ...

European stocks hit record highs; upbeat earnings from healthcare and basic resources sectors provided boosts. The FTSE 100 ...

AstraZeneca Plc reported better-than-expected profit and revenue in the fourth quarter and forecast further gains, helped by ...

European shares reached a record high and bond markets were under pressure as traders focused on global interest rate trends. While Britain's pound fell before a Bank of England rate cut, the STOXX ...

London's blue-chip index jumped to a record high on Thursday, lifted by shares of AstraZeneca after upbeat results and ahead ...

Astrazeneca PLC (AZN) on Thursday reported fourth-quarter earnings of $1.5 billion. On a per-share basis, the Cambridge, Britain-based company said it had net income of 48 cents. Earnings, adjusted ...

(Reuters) - European shares hovered near a record high on Thursday, buoyed by a raft of upbeat earnings, including drugmaker ...

AstraZeneca PLC on Thursday ended a strong year with better-than-expected fourth quarter earnings and said its pipeline would support further growth in 2025. The Cambridge-based pharmaceuticals firm ...

Futures had the FTSE 100 ticking up a further 28 points to reach 8,664 ahead of the Bank of England’s latest rate call, ...

Stocks rose as the busiest day of the earnings season got underway, with a decline in Treasury yields boosting risk sentiment ...